Transforming Diabetes Care: Pharmacist-Led Education and Its Impact on Patient Knowledge, Self-Management, and Health Outcomes

Not Applicable

Not yet recruiting

• Conditions: Diabetes Mellitus

• Registration Number: NCT06807333
• Lead Sponsor: Shifa International Hospital

Brief Summary

This interventional study is to evaluate the impact of pharmacist-led education on diabetic patients' knowledge, self-management, and overall health outcomes. Participants in this study will attend pharmacist-led educational sessions designed to improve their understanding of diabetes and self-care practices. Researchers will assess changes in patients' knowledge, self-management behaviors, and clinical health markers before and after the intervention. The study will compare pre- and post-intervention results to determine the effectiveness of pharmacist-led education in transforming diabetes care.

Detailed Description

The purpose of this study is to investigate whether pharmacist-led education can enhance the knowledge, self-management behaviors, and health outcomes of diabetic patients. Effective diabetes management requires a comprehensive understanding of the disease, adherence to lifestyle modifications, and consistent monitoring of health indicators. Poor knowledge and suboptimal self-care can lead to inadequate glycemic control, complications, and reduced quality of life. This study will evaluate the impact of pharmacist-led educational interventions on patients' motivation, diabetes-related knowledge, and self-care behaviors, as well as their effects on clinical outcomes, including improved HbA1c levels, reduced hypo- and hyperglycemic episodes, and enhanced patient satisfaction. By addressing these critical aspects, the study aims to highlight the transformative role of pharmacist-led education in advancing diabetes care and fostering sustainable, patient-centered healthcare practices.

Study Timeline

• Status Verified: 2025-01
• Study First Submitted: 2025-01-29
• Study First Submitted QC: 2025-01-29
• Last Update Submitted: 2025-01-29
• Study Start: 2025-02-01
• Study First Posted: 2025-02-04
• Last Update Posted: 2025-02-04
• Primary Completion: 2025-05-30
• Study Completion: 2025-07-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 385

Inclusion Criteria

• We will include all confirmed diabetic patients who visit the SIH endocrinology OPD Clinic during the study duration.

  • Both male and female patients visiting the Endocrinology Unit of the hospital will be eligible.
  • Patients with HbA1c levels greater than 8% will be included.
  • Both follow-up and newly diagnosed patients will be considered.
  • Patients who sign the informed consent form will be enrolled in the study.

Exclusion Criteria

• We will exclude patients with gestational diabetes mellitus (GDM).

  • Patients with central obesity will not be included in the study.
  • Type 1 diabetes mellitus (DM) patients under the age of 20 will be excluded.
  • Patients with inadequate medical history will be excluded from participation.
  • Patients with HbA1c levels less than 8% will not be included.
  • Patients who do not provide informed consent or express a lack of interest in the study will be excluded.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Diabetes Knowledge Score(DKQ-24)	3 months	Patient's diabetes knowledge will be assessed using the Diabetes Knowledge Questionnaire (DKQ). The DKQ is a tool used to evaluate a patient's understanding of diabetes, including aspects such as blood sugar control, diet, exercise, and medication management. It consists of close-ended questions, with scores ranging from 0 to 100, where a higher score indicates a better level of knowledge regarding diabetes management.
Diabetes Management Self-Efficacy Score (DMSQ-16)	3 months	Patient's diabetes self-management will be assessed using the Diabetes Self-Management Questionnaire (DMSQ). The DMSQ is a tool used to evaluate a patient's ability to manage their diabetes through self-care practices, including diet, physical activity, blood sugar monitoring, and medication adherence. It consists of close-ended questions, with scores ranging from 0 to 100, where a higher score reflects better self-management behaviors in managing diabetes.
HbA1C Levels (%)	3 months	Patient's health outcomes will be assessed using HbA1c levels. HbA1c (glycated hemoglobin) is a blood test used to measure a patient's average blood sugar level over the past 3 months. It is a key indicator of diabetes management and glycemic control. The HbA1c level is reported as a percentage, with lower percentages indicating better control of blood sugar. A target HbA1c level of less than 7% is typically recommended for most diabetic patients. The score can range from high percentages (indicating poor control) to lower percentages (indicating better glycemic control).

Trial Locations

Locations (1)

Shifa International Hospital; 🇵🇰 Islamabad, Pakistan